Influence of Shenlian decoction on early lesion of atherosclerosis in rats / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 66-71, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-289427
ABSTRACT
<p><b>OBJECTIVE</b>To establish the atherosclerosis models (AS) in rats and observe the change process of AS and Shenlian decoction's pharmacological effect.</p><p><b>METHOD</b>Two hundreds and forty rats were randomly divided into blank control group, model group, positive medicine group, the high-dose, middle dose and low-dose Shenlian decoction groups. Vascular pathological changes were observed by the methods of HE stain. The levels of TC, TG, LDL-C, HDL-C, NO in serum were determined respectively by enzyme colorimetric, clear and nitrate reductase methods. ET, TXB2, 6-keto-PGF1 alpha, TNF-alpha, IL-6 and IL-8 levels in serum were detected by radioimminoassay.</p><p><b>RESULT</b>Compared with the model group, vascular lesion of different doses of Shenlian decoction groups were significantly improved, the TG, NO, TXB2 levels in serum were significantly lower (P < 0.05), while high-dose Shenlian decoction can significantly reduce TNF-alpha, IL-6, IL-8 levels in serum (P < 0.05).</p><p><b>CONCLUSION</b>Shenlian decoction can inhibit the formation and development of AS by regulating blood lipids, improving endothelial function and reducing inflammatory factors release.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Blood
/
Drugs, Chinese Herbal
/
Random Allocation
/
Interleukin-6
/
Tumor Necrosis Factor-alpha
/
Rats, Wistar
/
Protective Agents
/
Disease Models, Animal
/
Drug Therapy
Type of study:
Controlled clinical trial
/
Prognostic study
Limits:
Animals
/
Humans
/
Male
Language:
Chinese
Journal:
China Journal of Chinese Materia Medica
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS